These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4365046)

  • 1. [Treatment of primary hyperlipoproteinemia type IIa and IIb with dextrothyroxine (author's transl)].
    Koschinsky T; Vogelberg KH; Gries FA
    Dtsch Med Wochenschr; 1974 Mar; 99(11):494-6. PubMed ID: 4365046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of primary lipoproteinemia type IIa and IIb with highly purified dextro-thyroxine (D-T4). Controlled study in ambulant conditions].
    Klemens UH; von Löwis P
    Dtsch Med Wochenschr; 1974 Mar; 99(11):487-93. PubMed ID: 4365703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hypercholesterolemia after myocardial infarction with D-thyroxine (author's transl)].
    Bommer J; Speders H; Ehrke V
    MMW Munch Med Wochenschr; 1975 Jan; 117(4):139-42. PubMed ID: 803622
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term treatment of hyperlipoproteinaemia, types IIa and IIb, with etiroxate (author's transl)].
    Schwartzkopff W; Russ E
    Dtsch Med Wochenschr; 1975 Apr; 100(15):815-21. PubMed ID: 164334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
    Schwartzkopff W; Russ E
    MMW Munch Med Wochenschr; 1975 May; 117(19):827-30. PubMed ID: 805950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
    Klemens UH; von Löwis P
    Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of etiroxate on serum lipids after myocardial infarction or in angina pectoris].
    Schwartzkopff W; Hoffmann H; Nijssen J; Etzel V
    Med Klin; 1976 Sep; 71(38):1555-63. PubMed ID: 185504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)].
    Mertz DP; Suermann I; Göhmann E
    MMW Munch Med Wochenschr; 1978 Aug; 120(34):1097-9. PubMed ID: 210375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The serum triglycerides and their role as a coronary risk factor (author's transl)].
    Pristautz H; Pavek P; Klein W
    Z Kardiol; 1977 May; 66(5):216-9. PubMed ID: 878547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
    MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of hyperlipoproteinemias type II a and II b using dextro-thyroxine or D,L-alpha-methyl-thyroxine-ethylester].
    Schwartzkopff W
    Verh Dtsch Ges Inn Med; 1972; 78():1621-3. PubMed ID: 4353151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of highly purified D-thyroxine ("Dyno") in hyperlipoproteinemias type II a and II b].
    von Löwis of Menar P; Klemens UH
    Verh Dtsch Ges Inn Med; 1972; 78():1623-5. PubMed ID: 4353152
    [No Abstract]   [Full Text] [Related]  

  • 16. [Decreasing effect of DL-alpha-methylthyroxine-ethylester, D-thyroxine (DT4), D-triiodothyronine (DT3) and a combination of DT4 + DT3 on serum lipids in primary hyperlipoproteinemia Type IIa and b].
    Koschinsky T; Gries FA; Vogelberg KH; Miss H; Jahnke K; Canzler H; Horster FA; Herrmann J; Wildmeister W; Krüskemper HL
    Verh Dtsch Ges Inn Med; 1974; 80():1262-4. PubMed ID: 4375893
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D-thyroxin in the therapy of type IIa and IIb hyperlipoproteinemias].
    Hempel RD; Müller G; Burchardt U
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 175-6. PubMed ID: 201111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR; Klemens UH; Vollmar LJ; Lang PD
    Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.